155 related articles for article (PubMed ID: 3225482)
1. [Analysis of the levels of CA125, CEA and CA19-9 in the cervical mucus samples obtained at various phases of the menstrual cycle and with inflammatory diseases of the uterine cervix].
Nanbu Y; Fujii S; Konishi I; Nonogaki H; Kobayashi F; Sagawa N; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Oct; 40(10):1519-24. PubMed ID: 3225482
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the levels of CA125, carcinoembryonic antigen, and CA19-9 in the cervical mucus for a detection of cervical adenocarcinoma.
Fujii S; Konishi I; Nanbu Y; Nonogaki H; Kobayashi F; Sagawa N; Mori T; Endo K
Cancer; 1988 Aug; 62(3):541-7. PubMed ID: 2455590
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the levels of CA125, CA19-9, and CEA in the cervical mucus helps a diagnosis of cervical adenocarcinomas].
Fujii S; Konishi I; Nanbu Y; Sagawa N; Nonogaki H; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Dec; 39(12):2193-4. PubMed ID: 3480920
[No Abstract] [Full Text] [Related]
4. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].
Kataoka A; Yakushiji M
Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782
[TBL] [Abstract][Full Text] [Related]
5. [Serum CA125 and CA19-9 levels in adenocarcinoma of the uterine cervix and endometrial carcinoma].
Ihara Y; Shimizu T; Kawaguchi K; Yomura W; Fujiwara T; Inoue K
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Nov; 40(11):1711-8. PubMed ID: 3235884
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of sialyl SSEA-1 antigen as tumor marker for ovarian cancer as compared with CA125, CA19-9, TPA, IAP, CEA and ferritin.
Yabushita H; Sawaguchi K; Hieda S; Ogawa A; Tomatsu A; Noguchi M; Ishihara M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):217-24. PubMed ID: 2566639
[TBL] [Abstract][Full Text] [Related]
7. Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen.
Matsuoka Y; Endo K; Kawamura Y; Yoshida T; Saga T; Watanabe Y; Koizumi M; Nakashima T; Konishi J; Yamaguchi N
Cancer; 1990 Feb; 65(3):506-10. PubMed ID: 2297641
[TBL] [Abstract][Full Text] [Related]
8. [Histochemical analysis of uterine cervical adenocarcinoma with reference to mucosubstances and distribution of CEA, CA125 and CA19-9].
Maruyama C; Yamamichi N; Konishi F
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):429-36. PubMed ID: 3163714
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor.
Tamakoshi K; Kikkawa F; Shibata K; Tomoda K; Obata NH; Wakahara F; Tokuhashi Y; Ishikawa H; Kawai M; Tomoda Y
Gynecol Oncol; 1996 Jul; 62(1):67-72. PubMed ID: 8690294
[TBL] [Abstract][Full Text] [Related]
10. IgG and IgA content of vaginal fluid during the menstrual cycle.
Usala SJ; Usala FO; Haciski R; Holt JA; Schumacher GF
J Reprod Med; 1989 Apr; 34(4):292-4. PubMed ID: 2715991
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].
Oishi T; Maruo T; Iwasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1595-604. PubMed ID: 3464659
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-related protein-8/14 is associated with proinflammatory cytokines in cervical mucus.
Kunimi K; Maegawa M; Kamada M; Yamamoto S; Yasui T; Matsuzaki T; Kuwahara A; Furumoto H; Ohmoto Y; Kido H; Irahara M
J Reprod Immunol; 2006 Aug; 71(1):3-11. PubMed ID: 16806487
[TBL] [Abstract][Full Text] [Related]
14. Are serum and biliary carcinoembryonic antigen and carbohydrate antigen19-9 determinations reliable for differentiation between benign and malignant biliary disease?
Akdoğan M; Parlak E; Kayhan B; Balk M; Saydam G; Sahin B
Turk J Gastroenterol; 2003 Sep; 14(3):181-4. PubMed ID: 14655062
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
[TBL] [Abstract][Full Text] [Related]
16. Effect of freeze-thaw cycles on serum measurements of AFP, CEA, CA125 and CA19-9.
Gao YC; Yuan ZB; Yang YD; Lu HK
Scand J Clin Lab Invest; 2007; 67(7):741-7. PubMed ID: 17852813
[TBL] [Abstract][Full Text] [Related]
17. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer].
Deguchi H; Tabuchi Y; Saitoh Y
Nihon Geka Gakkai Zasshi; 1988 May; 89(5):671-83. PubMed ID: 3166103
[TBL] [Abstract][Full Text] [Related]
18. Prolactin in human cervical mucus.
Chan PH; Chan SY; Ho PC; Tang GW
Int J Fertil; 1986; 31(3):204-6. PubMed ID: 2875960
[TBL] [Abstract][Full Text] [Related]
19. [Studies on pathogenesis of cervical carcinoma based on the analysis of growth and differentiation mechanism of cervical epithelium].
Konishi I
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):812-22. PubMed ID: 2172418
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
